fbpx

About Us

Our mission is to accelerate health equity.
We do this by delivering medication, technology, and services to patients facing cancer and other critical illnesses, focusing our energy on those no one else is helping.

Our History

Accelerating health equity for more than 25 years

The Max Foundation is a leading global health nonprofit dedicated to accelerating health equity. It started as a small volunteer group with the goal of providing access to education and support to Latin American families affected by leukemia. Since its founding in 1997, The Max Foundation has pioneered practical, scalable, high-quality solutions to bring life- extending and patient-centered healthcare to more than 100,000 people in over 80 countries, including the introduction of Max GPS, a U.S.-based patient navigation system. A lot has changed since then, but our focus remains the same – helping patients no one else will.

1997

The Max Foundation is born – A small group of volunteers joined forces with a mission to help Latin American families whose children were diagnosed with leukemia gain access to education and support. They name their grassroots organization The Max Foundation to honor Maximiliano “Max” Rivarola, who passed away from chronic myeloid leukemia (CML) in 1991 at age 17.

2001

A breakthrough treatment – Imatinib (Glivec®), the first oral drug of its kind that kills CML cells is approved by the U.S. Food and Drug Administration to treat cancer patients. This innovative treatment changed the natural course of the disease, turning CML from a deadly disease to a chronic condition. Before this breakthrough, CML patients were expected to live three to five years, depending on which stage they were diagnosed.

2001

Building a partnership – We partner with Novartis to develop and administer their Glivec® International Patient Assistance Program, a direct-to-patient international drug donation program providing cancer treatment (imatinib (Glivec®)) for patients in more than 70 low- and middle-income countries.

2008

A growing divide – A majority of CML patients taking imatinib and targeted therapies continue to see positive results and extend their lifespan. For those who become resistant to imatinib there are new, powerful oral medications that can be used as second- and third-line treatments with success. While many patients in the U.S. and high-income countries gain access to these highly effective treatments, a majority of patients and healthcare providers in low-income settings have yet to gain access to treat cancer patients.

2016

Bridging the gap – Five multinational pharmaceutical companies join our mission to give access to cancer treatment and quality care. Together, we form the Humanitarian Partnership for Access to Critical Treatment (Humanitarian PACT)—a commitment to providing access for patients who have no other means of receiving treatment.

2017

Expanding our work – We launch Max Access Solutions, the first global oncology model of its kind, offering a portfolio of cancer therapies, diagnostic solutions, and patient services with diverse partnerships that further aid patients with access to quality treatment and care.

2020

20 million daily doses – We celebrate surpassing 20 million daily doses of treatment delivered to patients worldwide since the launch of Max Access Solutions. Every dose is another day patients can face their cancer with dignity and hope.

Our Culture

“Our organization is rooted in a philosophy of people helping people. Our culture is one of belonging, love, and gratitude towards every individual associated with our work, be it a team member, an implementing partner, a donor, or a patient.”

-Pat Garcia-Gonzalez, CEO and Co-Founder

What drives us

We take a very human approach to every aspect of our work. We see patients, physicians, colleagues, partners, advocates, and donors as people first, and we support, learn from, and listen to one another. We move forward with urgency and a commitment to the lives of real people whom need help today.

Who we are

  • Resourceful problem solvers
  • Deeply connected to our mission
  • Warm and compassionate toward each patient, partner, funder, donor, and all our colleagues
  • Humble leaders, focused on impact
  • Willing to learn and open to change
  • Supportive team members, ready to collaborate and listen

Why we care

The Max Foundation is a fast-growing, ambitious, and deeply mission-driven nonprofit global health organization that believes in a world where:

  • All people can access high-impact medicines
  • Geography is not destiny
  • Everyone can strive for health with dignity and with hope

 

We forge strong collaborations with like-minded individuals representing global health, medicine, and the healthcare industry, and those committed to our mission and values.

Our Team

Hailing from the communities we serve and speaking more than 35 languages, our global team ensures that The Max Foundation’s health initiatives are as inclusive as they are impactful. Our diverse expertise, backgrounds, and cultures enable us to better understand the unique needs of patients and their caregivers. List of our global team members.

Leadership Team

Our Leadership Team, which is mission-focused and responsible for strategy, finances, and management, includes executives from our headquarters and region heads based in the U.S. and in regional offices around the world.

Pat Garcia-Gonzalez

Pat Garcia-Gonzalez

Cofounder and Chief Executive Officer

John Menapace

John Menapace

Chief Financial Officer and Vice President, Administration

Bryan Murphy-Eustis

Bryan Murphy-Eustis

Vice President, Program Strategy & Partnerships

Geoff Cook

Geoff Cook

Vice President, Communications and Development

Inés García González

Inés García González

Region Head for Latin America

Mei Ching Ong

Mei Ching Ong

Region Head for Asia Pacific, Eastern Europe and Central Asia

Viji Venkatesh

Viji Venkatesh

Region Head for South Asia

Catherina Scheepers

Catherina Scheepers

Region Head for Africa and The Middle East

J. Michael Wrigglesworth

J. Michael Wrigglesworth

Vice President, Program Operations

Board of Directors

Our Board of Directors is comprised of professionals dedicated to serving our mission. The Board provides governance and fiduciary oversight, along with guiding policy and assessment of organizational performance goals.

Paula Boultbee

Paula Boultbee

President of the Board

Pat Garcia-Gonzalez

Pat Garcia-Gonzalez

Cofounder and Chief Executive Officer

Robert Farmer

Robert Farmer

Honorary Board Member

Susan Jerian, MD

Susan Jerian, MD

Board Member; President and Founder, ONCORD, Inc.

Curt Malloy, JD, MPH

Curt Malloy, JD, MPH

Secretary of the Board; Chief Operating Officer at Cancer Research and Biostatistics (CRAB)

Jerald Radich, MD

Jerald Radich, MD

Board Member Professor; Clinical Research Division, Fred Hutchinson Cancer Research Center

Graciela Mabel Woloj Rothstein

Graciela Mabel Woloj Rothstein

Board Member Principal at MW Consulting

Maria Pia Ruffilli

Maria Pia Ruffilli

Board Member Retired, (former Senior Director International Public Affairs, Therapeutic Area Team, Team Leader – Pfizer)

Edgar Thomas

Edgar Thomas

Board Member, Certified Public Accountant Co-Founder, COO – Avise Inc

Join our team

See what openings are currently available at The Max Foundation.

Careers

Give hope this season

Support patients and families facing cancer around the world

Donate Now

This will close in 0 seconds